Dr. Kerri Purdy

Dermatologist, Halifax, NS

Dr. Purdy is an Associate Professor of Medicine and Division Head in the Division of Dermatology & Cutaneous Science at Dalhousie University in Halifax, Nova Scotia. Dr. Purdy has a full-time academic practice in Halifax.
After receiving her medical degree, Dr. Purdy completed her residency training in internal medicine, followed by dermatology, at Dalhousie University. Additionally, she has completed fellowship examinations in both specialties.
Dr. Purdy has been a member of regional and national advisory boards. She is a past president of the Canadian Dermatology Association.

11:25 AM - 12:10 PM Open Session

Nov 25

Let’s talk GPP!

In the broad category of psoriasis lies many diseases, including the broadly known and prevalent plaque psoriasis, as well as the far less common, and rare, conditions such as guttate, inverse, erythrodermic and pustular psoriasis. Despite sharing the term psoriasis, generalized pustular psoriasis (GPP) is a distinct condition whose disease pathway is different than the far more common plaque psoriasis. This open session will serve to provide a comprehensive review of GPP, including disease mechanisms and patient prevalence/predispositions. The conversation will then dive into the burden of disease and truly call to light the unmet needs that currently exists with patients suffering with GPP. Those in attendance will gain a better understanding of this rare disease.

Learning Objectives

  1. Increase awareness of generalized pustular psoriasis (GPP) as a different and distinct condition from plaque psoriasis
  2. Raise awareness and highlight the burden of disease on patients with GPP
2:05 PM - 3:05 PM UCB Open Session

Saturday APR 9, 2022

Be Informed about Recent Psoriasis Treatment Advances

Objectives of the session:

  • Analyze the bimekizumab clinical trial program, focusing on the efficacy and safety of bimekizumab in patients with moderate-to-severe psoriasis.
  • Share first-hand experience with bimekizumab from Canadian trialists.
  • Explore perspectives on the future landscape of psoriasis management in Canada.